HLN has been the topic of several other research reports. Deutsche Bank Aktiengesellschaft began coverage on Haleon in a report on Friday, July 29th. They set a hold rating on the stock. Morgan Stanley began coverage on Haleon in a research report on Friday, August 19th. They set an equal weight rating for the company. Barclays began coverage on Haleon in a research report on Monday, July 25th. They set an equal weight rating for the company. The Goldman Sachs Group began coverage on Haleon in a research report on Monday, July 25th. They set a buy rating for the company. Finally, Citigroup began coverage on Haleon in a research report on Monday, July 25th. They set a buy rating for the company. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Haleon currently has a consensus rating of Hold and an average target price of $285.00.
Haleon Trading Down 1.5 %
Shares of NYSE:HLN opened at $5.90 on Wednesday. Haleon has a 1-year low of $5.59 and a 1-year high of $8.50. The stock’s 50 day moving average price is $6.42.
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.
- Get a free copy of the StockNews.com research report on Haleon (HLN)
- The Worst May be Over for Target, But is the Stock Safe to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Two Fun Stocks The Insiders Are Buying
- Novavax Remains a Risk-On Stock in a Risk-Off Market
- General Mills: Superior Returns With Less Volatility
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.